[Survival of patients with lung cancer in combined treatment using hyperglycemia].
The paper is concerned with the results of a randomized study of combined therapy of lung cancer patients including large field radiotherapy (total irradiation of 20 Gy, daily fractionation of 4 Gy) and induced hyperglycemia (22-23 mmol/l). The use of new variants of combined therapy was shown to increase significantly the survival of patients, however therapeutic efficacy was different depending on the time of hyperglycemia: whether it was used before radiotherapy sessions or after their discontinuation.